SAM
COGT icon

Smartleaf Asset Management’s Cogent Biosciences COGT Stock Holding History

Smartleaf Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15K Buy
424
+134
+46% +$4.95K ﹤0.01% 2114
2025
Q4 		$10.8K Buy
290
+246
+559% +$6.92K ﹤0.01% 2367
2025
Q3 		$621 Buy
+44
New +$521 ﹤0.01% 2822
2025
Q1 		– Sell
-273
Closed -$2.1K – 2892
2024
Q4 		$2.1K Hold
273
– – ﹤0.01% 2523
2024
Q3 		$2.98K Hold
273
– – ﹤0.01% 2340
2024
Q2 		$2.3K Buy
+273
New +$2.07K ﹤0.01% 2175

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Smartleaf Asset Management's COGT Position: Q1 2026 in Review

Smartleaf Asset Management increased its Cogent Biosciences (COGT) stake by 46% in Q1 2026, buying an estimated $4.95K and bringing the position to 424 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

Smartleaf Asset Management first reported a position in COGT in Q2 2024 and has held it in 6 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Smartleaf Asset Management held 424 shares of Cogent Biosciences worth $15K as of Q1 2026.
  • Smartleaf Asset Management bought 134 Cogent Biosciences shares in Q1 2026, an estimated $4.95K.
  • Cogent Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2114 holding.
  • Smartleaf Asset Management first reported a position in Cogent Biosciences in Q2 2024 and has held it in 6 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.